Skip to main content
Premium Trial:

Request an Annual Quote

Gene-IT Licenses Sequence-Comparing Software to Pfizer

NEW YORK, Feb. 18 - Gene-IT over the weekend said that Pfizer has licensed its LASSAP gene sequence-comparing software.


Under terms of the deal, Pfizer scientists will be allowed to use the LASSAP technology for a number of tasks, including mining public and private mammalian genome databases.


Financial terms of the agreement were not disclosed.


Gene-IT, a privately held company based in France, launched LASSAP four years ago. The company has similar deals with Bayer Crop Science/Biogemma, Derwent, BioMerieux, DuPont, Servier Labs, and Organon.


In October 2001, Gene-IT opened a subsidiary in Los Altos, Calif., to help it carve a bigger foothold in the US market.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.